-+ 0.00%
-+ 0.00%
-+ 0.00%

Supernus Pharmaceuticals: Q4 Earnings Insights

Benzinga·02/24/2026 21:10:27
Listen to the news

Supernus Pharmaceuticals (NASDAQ:SUPN) reported its Q4 earnings results on Tuesday, February 24, 2026 at 04:01 PM.

Here's what investors need to know about the announcement.

Earnings

Supernus Pharmaceuticals missed estimated earnings by -131.82%, reporting an EPS of $-0.07 versus an estimate of $0.22.

Revenue was up $37.41 million from the same period last year.

Overview of Past Earnings

In the previous quarter, the company missed on EPS by $1.42, resulting in a 17.35% drop change in the share price the following day.

Here's a look at Supernus Pharmaceuticals's past performance:

Quarter Q3 2025 Q2 2025 Q1 2025 Q4 2024
EPS Estimate 0.62 0.42 0.37 0.52
EPS Actual -0.80 0.40 -0.21 0.27
Revenue Estimate 180.96M 154.10M 147.94M 155.25M
Revenue Actual 192.10M 180.92M 149.82M 174.16M

To track all earnings releases for Supernus Pharmaceuticals visit their earnings calendar here.

This article was generated by Benzinga's automated content engine and reviewed by an editor.